Levetiracetam Sustained-release Granules(Zhejiang Saimo Pharma)

左乙拉西坦缓释颗粒(浙江赛默制药)

Report date: 2025/09/23 09:50:51

Base Information

Drug NameLevetiracetam Sustained-release Granules(Zhejiang Saimo Pharma)
Drug Alias Name左旋乙拉西坦左乙拉西坦缓释颗粒(2.2改良型)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSynaptic vesicle glycoprotein 2A modulators
TargetsSynaptic vesicle glycoprotein 2A
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A